Aurora Cannabis Inc. Stock price

Equities

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-03-18 pm EDT 5-day change 1st Jan Change
5 CAD +15.21% Intraday chart for Aurora Cannabis Inc. +22.55% -23.08%
Sales 2024 * 272M 201M Sales 2025 * 320M 236M Capitalization 237M 175M
Net income 2024 * -57M -42.11M Net income 2025 * -3M -2.22M EV / Sales 2024 * 0.87 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.74 x
P/E ratio 2024 *
-3.01 x
P/E ratio 2025 *
-72.3 x
Employees 1,130
Yield 2024 *
-
Yield 2025 *
-
Free-Float 9.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+15.21%
1 week+16.82%
Current month+17.10%
1 month-3.85%
3 months-21.88%
6 months-62.41%
Current year-23.08%
More quotes
1 week
3.84
Extreme 3.84
5.34
1 month
3.84
Extreme 3.84
5.34
Current year
3.84
Extreme 3.84
6.60
1 year
3.84
Extreme 3.84
15.50
3 years
3.84
Extreme 3.84
128.80
5 years
3.84
Extreme 3.84
1 640.41
10 years
3.84
Extreme 3.84
1 948.81
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 20-07-05
Director of Finance/CFO 52 Feb. 20
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 67 18-07-24
Director/Board Member 60 16-05-19
Director/Board Member 52 15-08-09
More insiders
Date Price Change Volume
24-03-18 5 +15.21% 1,873,458
24-03-15 4.34 +11.00% 1,301,541
24-03-14 3.91 -1.76% 680,948
24-03-13 3.98 +0.76% 682,122
24-03-12 3.95 -3.19% 770,861

Delayed Quote Toronto S.E., March 18, 2024 at 04:00 pm EDT

More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
5 CAD
Average target price
9.681 CAD
Spread / Average Target
+93.62%
Consensus
  1. Stock
  2. Equities
  3. Stock Aurora Cannabis Inc. - Toronto S.E.